On June 23, 2026, patient advocacy groups in the United States released a comprehensive report on the financial impact of oncology treatments and the role of international sourcing. The soaring cost of specialty medicines like Keytruda (Pembrolizumab) and Herceptin (Trastuzumab) has driven many American families to seek safe, alternative sourcing methods under FDA personal importation guidelines.

At Critical Kare Pharma, we support patient access by supplying authentic oncology medications from authorized global distributors. By bypassing high retail markups, we help reduce the burden of financial toxicity while maintaining strict clinical standards.

Understanding USA Import Guidelines

• FDA Personal Importation Policy: The FDA allows personal imports of prescription medications under specific conditions, including when the drug is for a serious condition and no effective local alternative is available, or when importing offers a viable way to maintain ongoing therapy.
• Cost Optimization: Sourcing directly from certified international channels can save patients 30% to 70% compared to local retail pharmacy prices.
• Clinical Integrity: All imported medicines are identical in formulation to those found in US pharmacies and are accompanied by a Certificate of Analysis (COA).

Healthcare affordability is a critical component of successful cancer care. By coordinating with US customs brokers and providing tracked, cold-chain shipping, Critical Kare Pharma ensures that American patients can access their medication safely, affordably, and on time. Your health is our highest priority.